Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
- Specification
- Q & A
- Customer Review
vWA: 18
FGA: 20,25
Amelogenin: X
TH01: 6,8
TPOX: 8
CSF1P0: 12,13
D5S818: 11
D13S317: 12,14
D7S820: 9,10
Shipping Condition: Room Temperature
Key components include the validation of cell lines, maintenance of cell culture conditions, regular monitoring of cell morphology and viability, and the use of standardized protocols and reagents.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
Reliable products
The compatibility and reliability of these products have significantly improved the precision and reproducibility of our cellular applications, supporting the advancement of our research goals.
03 Jan 2023
Ease of use
After sales services
Value for money
Write your own review
Description: Established from the primary lesion resected from a 76-year-old woman with bulky, moderately differentiated squamous cell carcinoma of the vulva in 1984; cells were reported to express an elevated number of high affinity EGF receptors, to carry gene amplification at 11q13 and to be tumorigenic in nude mice
Description: Established from the solid tumor of a 52-year-old Caucasian man with advanced stage malignant bile duct carcinoma (patient had not received any chemotherapy prior to cell explantation) in 1984 and three consecutive passages in female nu/nu mice (NMRI); primary tumor histology: large cell adenocarcinoma of low differentiation, metastasizing (ascites in patient); human character of cell line confirmed by karyotype in passage #34 of in vitro culture (1986)
Description: Subclone of ACH1P which was established by fusion of the JEG-3-derived HGPRT-defective mutant cell line AC1-1 with primary male trophoblast cells isolated from term human chorion laeve; described as possessing both, a distinct karyotype and a distinct expression pattern of tumor-related genes
Description: One of five phenotypically and cytogenetically distinct subclones of a hybrid (ACH1P) formed by fusing an HGPRT-defective mutant (AC1-1) of JEG-3 human choriocarcinoma with primary human trophoblast (chorion laeve) cells
Description: Established by somatic hybridization of primary male trophoblast cells and the HGPRT-defective choriocarcinoma cell line AC1-1 which was originally derived from cell line JEG-3
Description: NTERA-2 was cloned from cell line TERA-2 which was derived from a metastatic teratocarcinoma of a 22-year-old Caucasian male; cell line also known as NT-2
